Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rockley Photonics Holdings Ltd | 1,891,521 | reported | 21 Oct 2022 | tx 2+3,783,042 |
| ACCENDRA HEALTH INC/VA/ | 127,158 | reported | 08 Feb 2018 | tx 18+135,571−20,790 |
| BIOMARIN PHARMACEUTICAL INC | 126,926 | reported | 30 Dec 2025 | tx 88+346,960−189,884 |
| TELEFLEX INC | 33,155 | reported | 28 Feb 2012 | tx 14+239,994.71 |
| STAAR SURGICAL CO | 18,300 | reported | 20 May 2016 | tx 19+145,300−28,000 |
| ADVANCED MEDICAL OPTICS INC | 0 | reported | 26 Feb 2009 | tx 43+413,200−649,770.47 |
| Intersect ENT, Inc. | 0 | reported | 13 May 2022 | tx 19+287,472−287,472 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Dec 2025 | GIFT | BIOMARIN PHARMACEUTICAL INC | 500 | 0.00 USD | |
| 20 May 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 6,650 | 0.00 USD | |
| 03 Jun 2024 | TAX_WITHHOLDING | BIOMARIN PHARMACEUTICAL INC | 5,451 | 76.41 USD | |
| 03 Jun 2024 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 6,600 | 63.10 USD | |
| 03 Jun 2024 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 6,600 | 0.00 USD | deriv |
| 21 May 2024 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 7,080 | 0.00 USD | |
| 08 Jan 2024 | GIFT | BIOMARIN PHARMACEUTICAL INC | 3,000 | 0.00 USD | |
| 23 May 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 4,190 | 0.00 USD | |
| 12 May 2023 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 8,500 | 67.81 USD | |
| 12 May 2023 | TAX_WITHHOLDING | BIOMARIN PHARMACEUTICAL INC | 6,137 | 93.93 USD | |
| 12 May 2023 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 8,500 | 0.00 USD | deriv |
| 21 Oct 2022 | GRANT_AWARD | Rockley Photonics Holdings Ltd | 1,891,521 | 0.00 USD | deriv |
| 21 Oct 2022 | GRANT_AWARD | Rockley Photonics Holdings Ltd | 1,891,521 | 0.00 USD | deriv |
| 24 May 2022 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 4,980 | 0.00 USD | |
| 13 May 2022 | TENDER | Intersect ENT, Inc. | 57,230 | 28.25 USD | |
| 13 May 2022 | TENDER | Intersect ENT, Inc. | 40,607 | 28.25 USD | |
| 13 May 2022 | TENDER | Intersect ENT, Inc. | 65,759 | 28.25 USD | |
| 13 May 2022 | TENDER | Intersect ENT, Inc. | 34,000 | 28.25 USD | deriv |
| 13 May 2022 | TENDER | Intersect ENT, Inc. | 74,852 | 28.25 USD | deriv |
| 02 May 2022 | SALE | BIOMARIN PHARMACEUTICAL INC | 3,860 | 82.09 USD | |
| 02 May 2022 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 8,500 | 37.46 USD | |
| 02 May 2022 | SALE | BIOMARIN PHARMACEUTICAL INC | 18 | 82.12 USD | anomaly |
| 02 May 2022 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 8,500 | 0.00 USD | deriv |
| 02 Feb 2022 | TAX_WITHHOLDING | Intersect ENT, Inc. | 2,329 | 27.31 USD | |
| 01 Feb 2022 | GRANT_AWARD | Intersect ENT, Inc. | 36,738 | 0.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 16 Mar 2020.